Form: 10-K

Annual report pursuant to Section 13 and 15(d)

April 15, 2022

Exhibit 21.1

​

Subsidiaries of the Registrant

​

​

​

Jade Therapeutics, Inc.

(United States)

Kiora Pharmaceuticals GmbH

(Austria)

Bayon Therapeutics, Inc.

(United States)

Kiora Pharmaceuticals Pty Ltd

(Australia)

​